La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Placebo And NotM. Panisset

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000199 Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Negre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarie [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France]A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
000396 Emmanuelle Pourcher [Canada, France] ; Sophie Remillard [Canada] ; Henri Cohen [Canada, France]Affect in Parkinson's disease: validation of the two-factor approach
000573 C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Wemer Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics
000575 M. Stacy [États-Unis] ; D. Silver [États-Unis] ; T. Mendis [Canada] ; J. Sutton [États-Unis] ; A. Mori [États-Unis] ; P. Chaikin [États-Unis] ; N. M. Sussman [États-Unis]A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
000579 Joseph Jankovic [États-Unis] ; Ray L. Watts [États-Unis] ; Wayne Martin [Canada] ; Babak Boroojerdi [États-Unis]Transdermal rotigotine : Double-blind, placebo-controlled trial in parkinson disease
000730 Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Expectation and the placebo effect in parkinson's disease patients with subthalamic nucleus deep brain stimulation
000858 Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada]Placebo mechanisms and reward circuitry: Clues from Parkinson's disease
000B07 Raul De La Fuente-Fernandez [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022